DNA Ginkgo Bioworks Holdings, Inc.
$10.66
Ginkgo Bioworks Holdings, Inc. (DNA) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.58 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +14.8% since its last earnings release on August 5, 2026.
Ginkgo Bioworks Reported Earnings
Wednesday, August 5, 2026 · 12:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 12
Thursday · After Close
Earnings Whisper
-
vs ($0.58)
Rev est $20.5M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$7.56
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Ginkgo Bioworks Holdings, Inc.
Ginkgo is building a platform to enable customers to program cells as easily as we can program computers.
Sector
Healthcare
Industry
Biotechnology
Charts powered in part by Lightweight Charts™ by TradingView.